Study Reveals Distinct Microbiome Changes in Long Covid Patients

A recent study published in the European Respiratory Journal has unveiled significant differences in the oral and lung microbiomes of individuals suffering from long Covid. Conducted by a team from the University of Dundee, UK, the research aims to understand why certain patients develop long-lasting symptoms following Covid-19 infections. The study's findings suggest that these microbiome alterations could be linked to various respiratory, cognitive, and digestive issues experienced by long Covid patients.

The research is part of the PHOSP-COVID initiative, which focuses on understanding the long-term effects of Covid-19. It involved 771 participants who were treated for the virus in 38 hospitals across the UK between February 2020 and March 2021. Participants were categorized into four groups based on the severity of their symptoms five months post-discharge: very severe, severe, moderate, and mild. This classification allowed researchers to analyze the relationship between symptom severity and microbiome changes.

Six months after their hospital discharge, researchers collected saliva and sputum samples from the participants to identify microbial presence through DNA sequencing. The analysis revealed that individuals with very severe long Covid exhibited notable differences in their oral and lung microbiomes compared to those with milder symptoms. Specific symptoms, such as reduced lung function and cognitive difficulties, were also associated with distinct microbiome profiles, including an abundance of lactic acid-producing bacteria linked to inflammation.

The implications of these findings extend beyond individual health, as long Covid continues to impact millions globally, affecting their ability to work and perform daily activities. Professor James Chalmers, who led the study, emphasized the need for further research to determine whether these microbiome changes precede or follow Covid infections. Understanding these dynamics could pave the way for innovative treatments, potentially utilizing antibiotics or probiotics to modify the microbiome.

Looking ahead, the PHOSP-COVID project will continue to explore the complexities of long Covid, including the role of inflammation and potential treatments. As the global community grapples with the ongoing effects of the pandemic, this research provides a critical foundation for future studies aimed at alleviating the burden of long Covid on individuals and healthcare systems alike.